Title: Ventricular Assist Device Market is Driven by Rising Incidence of Cardiovascular Diseases
1Product Type - Left Ventricular Assist Device
(LVAD), Right Ventricular Assist Device (RVAD),
Bi-Ventricular Assist Device (Bi-VAD), and Total
Artificial Heart (TAH) Indication - Bridge To
Transplant (BTT), Destination Therapy (DT), and
Bridge To Recovery(BTR)- Forecast 2016-2024
Ventricular Assist Device Market
2Table of Content
Sr. No. Content
Chapter1 Preface
Chapter 2 Assumptions and Research Methodology
Chapter 3 Executive Summary North America Ventricular Assist Device Market
Chapter 4 Market Overview
Chapter 5 North America Ventricular Assist Device Market Analysis and Forecast, By Product Type
Chapter 6 North America Ventricular Assist Device Market Analysis and Forecast, By Indication
Chapter 7 North America Ventricular Assist Device Market Analysis and Forecast, By Region
Chapter 8 U.S. Ventricular Assist Device Market Analysis and Forecast
Chapter 9 Canada Ventricular Assist Device Market Analysis and Forecast
Chapter 10 Competition Landscape
3Ventricular Assist Device Market Snapshot
- Advance Heart Failure is characterized as
weakening of the heart caused due to failure of
the left ventricle, due to which the heart is
unable to pump blood to different parts of the
body. According to the AHA (American Heart
Association), 5.7 Mn people in the U.S suffer
from heart failure and 300,000 die each year of
heart failure. - The demand within the global market for
ventricular assist devices has been escalating at
a stellar pace, majorly due to advancements in
the medical fraternity. - Market related factors such as technological
developments, patent expiry, recent approvals,
investment in clinical studies and acquisitions
by leading players in the market, and historical
year-on-year growth have been taken into
consideration while estimating the market size.
4(No Transcript)
5Reports Highlights
- The North America Market for ventricular Assist
Devices offered an opportunity worth US0.49 bn
in 2015. Expanding at an impressive CAGR of 9.20
during the period from 2016 to 2024, the market
is projected to reach US1.07 bn by 2024. - The demand within the global market for
ventricular assist devices has been escalating at
a stellar pace, majorly due to advancements in
the medical fraternity. The healthcare industry
has become open to the induction of new
technologies that can assist medical
practitioners and specialists during treatment. - The number of annual patients hosted by
healthcare centers and hospitals has been rising
at a stellar rate in recent times. This has in
turn generated huge-scale revenues for the
healthcare industry. An increase in the revenue
base of hospitals allows them to install seamless
technologies.
Request Sample
6(No Transcript)